Literature DB >> 29275819

Stem cell therapy in necrotizing enterocolitis: Current state and future directions.

Natalie A Drucker1, Christopher J McCulloh2, Bo Li3, Agostino Pierro3, Gail E Besner2, Troy A Markel4.   

Abstract

Stem cell therapy is a promising treatment modality for necrotizing enterocolitis. Among the many promising stem cells identified to date, it is likely that mesenchymal stem cells will be the most useful and practical cell-based therapies for this condition. Using acellular components such as exosomes or other paracrine mediators are promising as well. Multiple mechanisms are likely at play in the positive effects provided by these cells, and further research is underway to further elucidate these effects.
Copyright © 2018 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Intestine; Ischemia; Necrotizing enterocolitis; Neonatal; Premature; Stem cell therapy

Mesh:

Year:  2017        PMID: 29275819      PMCID: PMC5745058          DOI: 10.1053/j.sempedsurg.2017.11.011

Source DB:  PubMed          Journal:  Semin Pediatr Surg        ISSN: 1055-8586            Impact factor:   2.754


  87 in total

1.  Functional engraftment of colon epithelium expanded in vitro from a single adult Lgr5⁺ stem cell.

Authors:  Shiro Yui; Tetsuya Nakamura; Toshiro Sato; Yasuhiro Nemoto; Tomohiro Mizutani; Xiu Zheng; Shizuko Ichinose; Takashi Nagaishi; Ryuichi Okamoto; Kiichiro Tsuchiya; Hans Clevers; Mamoru Watanabe
Journal:  Nat Med       Date:  2012-03-11       Impact factor: 53.440

2.  Fusion of bone-marrow-derived cells with Purkinje neurons, cardiomyocytes and hepatocytes.

Authors:  Manuel Alvarez-Dolado; Ricardo Pardal; Jose M Garcia-Verdugo; John R Fike; Hyun O Lee; Klaus Pfeffer; Carlos Lois; Sean J Morrison; Arturo Alvarez-Buylla
Journal:  Nature       Date:  2003-10-12       Impact factor: 49.962

Review 3.  History and perspective of stem cell research.

Authors:  Ariff Bongso; Mark Richards
Journal:  Best Pract Res Clin Obstet Gynaecol       Date:  2004-12       Impact factor: 5.237

4.  Toll-like receptor-4 inhibits enterocyte proliferation via impaired beta-catenin signaling in necrotizing enterocolitis.

Authors:  Chhinder P Sodhi; Xia-Hua Shi; Ward M Richardson; Zachary S Grant; Richard A Shapiro; Thomas Prindle; Maria Branca; Anthony Russo; Steven C Gribar; Congrong Ma; David J Hackam
Journal:  Gastroenterology       Date:  2009-09-26       Impact factor: 22.682

Review 5.  Dissecting paracrine effectors for mesenchymal stem cells.

Authors:  Stefania Bruno; Federica Collino; Ciro Tetta; Giovanni Camussi
Journal:  Adv Biochem Eng Biotechnol       Date:  2013       Impact factor: 2.635

6.  Amniotic fluid inhibits Toll-like receptor 4 signaling in the fetal and neonatal intestinal epithelium.

Authors:  Misty Good; Richard H Siggers; Chhinder P Sodhi; Amin Afrazi; Feras Alkhudari; Charlotte E Egan; Matthew D Neal; Ibrahim Yazji; Hongpeng Jia; Joyce Lin; Maria F Branca; Congrong Ma; Thomas Prindle; Zachary Grant; Sapana Shah; Dennis Slagle; Jose Paredes; John Ozolek; George K Gittes; David J Hackam
Journal:  Proc Natl Acad Sci U S A       Date:  2012-06-25       Impact factor: 11.205

7.  Modeling the interactions of bacteria and Toll-like receptor-mediated inflammation in necrotizing enterocolitis.

Authors:  Julia Arciero; G Bard Ermentrout; Richard Siggers; Amin Afrazi; David Hackam; Yoram Vodovotz; Jonathan Rubin
Journal:  J Theor Biol       Date:  2012-12-10       Impact factor: 2.691

8.  Harvest tissue source does not alter the protective power of stromal cell therapy after intestinal ischemia and reperfusion injury.

Authors:  Amanda R Jensen; Morenci M Manning; Sina Khaneki; Natalie A Drucker; Troy A Markel
Journal:  J Surg Res       Date:  2016-05-11       Impact factor: 2.192

9.  Mesenchymal stem cell therapy modulates the inflammatory response in experimental traumatic brain injury.

Authors:  Layla T Galindo; Thais R M Filippo; Patricia Semedo; Carolina B Ariza; Caroline M Moreira; Niels O S Camara; Marimelia A Porcionatto
Journal:  Neurol Res Int       Date:  2011-06-09

10.  Exosomes: secreted vesicles and intercellular communications.

Authors:  Clotilde Théry
Journal:  F1000 Biol Rep       Date:  2011-07-01
View more
  17 in total

1.  Therapeutic Effects of Mesenchymal Stem Cells Derived From Bone Marrow, Umbilical Cord Blood, and Pluripotent Stem Cells in a Mouse Model of Chemically Induced Inflammatory Bowel Disease.

Authors:  Argyro Kagia; Maria Tzetis; Emmanuel Kanavakis; Despina Perrea; Irene Sfougataki; Anny Mertzanian; Ioanna Varela; Aikaterini Dimopoulou; Angeliki Karagiannidou; Evgenios Goussetis
Journal:  Inflammation       Date:  2019-10       Impact factor: 4.092

2.  Potential role of stem cells in disease prevention based on a murine model of experimental necrotizing enterocolitis.

Authors:  Courtney Pisano; Gail E Besner
Journal:  J Pediatr Surg       Date:  2018-09-05       Impact factor: 2.545

3.  Low technology, mild controlled hypothermia for necrotizing enterocolitis treatment: an initiative to improve healthcare to preterm neonates.

Authors:  Walusa Assad Gonçalves-Ferri; Cristina Helena Faleiros Ferreira; Laryssa de Carli de Almeida Couto; Thaissa Rodrigues Souza; Thayane de Castro Peres; Fabio Carmona; Davi Casale Aragon; Gerson Crott; Marisa M Mussi-Pinhata; Jose Simon Camelo Junior; Anelise Roosch; Lourenço Sbragia Neto
Journal:  Eur J Pediatr       Date:  2021-04-24       Impact factor: 3.183

4.  Inhibiting hydrogen sulfide production in umbilical stem cells reduces their protective effects during experimental necrotizing enterocolitis.

Authors:  Natalie A Drucker; Jan P Te Winkel; W Christopher Shelley; Kenneth R Olson; Troy A Markel
Journal:  J Pediatr Surg       Date:  2019-03-01       Impact factor: 2.545

5.  Age disparities in intestinal stem cell quantities: a possible explanation for preterm infant susceptibility to necrotizing enterocolitis.

Authors:  Brian D Hosfield; W Christopher Shelley; Fikir M Mesfin; John P Brokaw; Krishna Manohar; Jianyun Liu; Hongge Li; Anthony R Pecoraro; Kanhaiya Singh; Troy A Markel
Journal:  Pediatr Surg Int       Date:  2022-10-08       Impact factor: 2.003

6.  Intestinal Regulatory T Cells.

Authors:  Vanessa R Figliuolo da Paz; Deepa R Jamwal; Pawel R Kiela
Journal:  Adv Exp Med Biol       Date:  2021       Impact factor: 2.622

Review 7.  Extracellular Vesicles as a Potential Therapy for Neonatal Conditions: State of the Art and Challenges in Clinical Translation.

Authors:  Andreea C Matei; Lina Antounians; Augusto Zani
Journal:  Pharmaceutics       Date:  2019-08-11       Impact factor: 6.321

Review 8.  Recent advances in understanding necrotizing enterocolitis.

Authors:  Mashriq Alganabi; Carol Lee; Edoardo Bindi; Bo Li; Agostino Pierro
Journal:  F1000Res       Date:  2019-01-25

9.  Human placental-derived stem cell therapy ameliorates experimental necrotizing enterocolitis.

Authors:  Victoria G Weis; Anna C Deal; Gehad Mekkey; Cara Clouse; Michaela Gaffley; Emily Whitaker; Cole B Peeler; Jared A Weis; Marshall Z Schwartz; Anthony Atala
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2021-02-10       Impact factor: 4.052

10.  Experimental Modeling of Necrotizing Enterocolitis in Human Infant Intestinal Enteroids.

Authors:  Christie Buonpane; Guillermo Ares; Carrie Yuan; Camille Schlegel; Heather Liebe; Catherine J Hunter
Journal:  J Invest Surg       Date:  2020-10-26       Impact factor: 2.533

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.